BioMaric

Rijvisschestraat 118/1

9000 Gent

BE

BioMaric

Foundation date

13-08-2001

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

BioMaric is a Belgian biotechnology company specialised in the development of diagnostic assays for infectious diseases (such as HIV, HCV and HTLV) used for blood bank screening and laboratory diagnostics.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    Wednesday December 1st 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    Wednesday December 1st 2021